Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

13744

Reinforcement Learning From Verifiable Rewards In Cns Drug Optimization

Part of Topic

Drug Development -> Nonhuman -> Lead optimization studies

REINFORCEMENT LEARNING FROM VERIFIABLE REWARDS IN CNS DRUG OPTIMIZATION
DAVID SCOTT LEWIS, ENRIQUE ZUECO, HALEY YI
AIXC BIO, ZARAGOZA, SPAIN | REPORTS@AIXCBIO.COM

ALZHEIMER'S ASSOCIATION
AAIC '26

KEY TAKEAWAY
Verifiable Physics-Based Rewards Enable True Autonomous Self-Improvement for Multi-Parameter CNS Drug Optimization.

INTRODUCTION
Designing Brain-Penetrant Therapeutics requires balancing multi-parameter constraints:
- Solubility vs. Blood-Brain Barrier (BBB) permeability
- Lipophilicity

Why current methods (like pure LLMs) fail:
Pure LLMs fail without verifiable biological feedback rewards.

METHODS
Primary Objectives:
- Autonomous CNS optimization goals
- Multi-target BBB crossing and optimal lead generation

Reward Calculation Detail:
- Tau dock score -> Deterministic Physics-Based Reward Function -> Verifiable Scalar Reward
- BBB value -> Deterministic Physics-Based Reward Function -> Verifiable Scalar Reward

This is superior to scalar reward models based on human preference.

CLOSED-LOOP SYSTEM FOR TAU INHIBITORS
SMILES Strings -> AI AGENT -> TEST-TIME RECURSIVE THINKING -> VERIFIABLE REWARD EVALUATION (SIMULATION)
VERIFIABLE REWARD EVALUATION (SIMULATION) -> MOLECULAR DOCKING (Tau Aggregation) + In Silico BLOOD-BRAIN BARRIER (BBB) PERMEABILITY SIMULATION -> HARD SCALAR REWARDS -> FEEDBACK -> AI AGENT (Loop repeats)

RESULTS
SUCCESS RATE IMPROVEMENT
(Bar chart showing +42% improvement)

BINDING AFFINITY vs. BBB PERMEABILITY
(Scatter plot showing Binding Affinity vs. BBB Permeability)

Rapid Autonomous Self-Improvement
(Arrow pointing right indicating Time, with molecular structures shown)

CONCLUSIONS
AUTONOMOUS SELF-DRIVING DRUG DISCOVERY PIPELINE
AUTOMATED SYNTHESIS -> TESTING -> AI-LED DESIGN (Loop)

- Significance: Establishes a verifiable path towards faster, more effective Alzheimer's drug discovery.
- Validates physics-grounded AI learning as scalable for complex multi-objective optimization.
- Future Directions: Generalization to other target classes; Regulatory pathways for autonomous discovery frameworks.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.